Table 2 |
||||
|
Associations between CXCL13 and clinical and ultrasonographic measures of disease activity at baseline |
||||
|
Univariable analyses |
Multivariable analyses* |
|||
|
|
||||
|
Spearman R (95% CI) |
P |
Partial correlation |
P |
|
|
|
||||
|
DAS44 |
0.35 (0.21 to 0.48) |
< 0.001 |
0.30 |
< 0.001 |
|
SDAI |
0.28 (0.12 to 0.43) |
< 0.001 |
0.22 |
< 0.001 |
|
SJC |
0.28 (0.12 to 0.43) |
< 0.001 |
0.26 |
< 0.001 |
|
TJC |
0.10 (-0.06 to 0.26) |
0.22 |
- |
- |
|
RAI |
0.12 (-0.04 to 0.28) |
0.14 |
0.06 |
0.21 |
|
CRP |
0.42 (0.29 to 0.54) |
< 0.001 |
0.38 |
< 0.001 |
|
ESR |
0.41 (0.27 to 0.53) |
< 0.001 |
0.35 |
< 0.001 |
|
US-GS score |
0.27 (0.10 to 0.44) |
0.003 |
0.31 |
< 0.001 |
|
US-PD score |
0.26 (0.08 to 0.42) |
0.005 |
0.32 |
< 0.001 |
|
|
||||
|
Results from Spearman R and multivariable linear regression analyses.*Adjusted for age, gender, symptoms duration, ACPA positivity. CRP, C-reactive protein; DAS44, Disease Activity Score in 44 joints; ESR, erythrocyte sedimentation rate; RAI, Ritchie Articular Index; SDAI, Simplified Disease Activity Score; SJC, swollen joint count; TJC, tender joint count; US-GS, Grey-Scale; US-PD, Power Doppler |
||||
|
Bugatti et al. Arthritis Research & Therapy 2012 14:R34 doi:10.1186/ar3742 |
||||